This HTML5 document contains 129 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q43156241
rdf:type
wikibase:Item
schema:description
articol științific vedecký článok wissenschaftlicher Artikel 2010年学术文章 scientific article published in February 2010 مقالة علمية نشرت في فبراير 2010 2010年學術文章 ফেব্রুয়ারি ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ article científic научна статия artikel ilmiah bài báo khoa học scienca artikolo artigo científico 2010年の論文 tudományos cikk artigo científico article scientific tieteellinen artikkeli 2010年学术文章 vitenskapelig artikkel 2010年學術文章 article scientifique мақолаи илмӣ מאמר מדעי artikull shkencor artículo científico publicado en 2010 научная статья artykuł naukowy vědecký článek научни чланак 2010年学术文章 2010年学术文章 articolo scientifico 2010年學術文章 artigo científico 2010年學術文章 scientific article published in February 2010 bilimsel makale 2010年学术文章 teaduslik artikkel vitskapeleg artikkel наукова стаття, опублікована в лютому 2010 2010年學術文章 2010年学术文章 vetenskaplig artikel wetenschappelijk artikel научни чланак videnskabelig artikel บทความทางวิทยาศาสตร์ naučni članak 2010년 논문 სამეცნიერო სტატია 2010 nî lūn-bûn artikulong pang-agham artículu científicu espublizáu en 2010 επιστημονικό άρθρο scientific article published in February 2010
p:P577
wds:Q43156241-023F3FF1-D7EC-454C-9959-D1764F36B9C6
wdt:P577
2010-02-01T00:00:00Z
p:P2093
wds:Q43156241-1ED6C3E1-30A6-4126-A12C-5BFA6BF37402 wds:Q43156241-31B1FACE-74E1-498E-A467-0C0B80C980E2 wds:Q43156241-4BA70B2B-D82A-4AEC-96AC-BA5F49EB0F05 wds:Q43156241-461436D4-E4F3-4671-B606-8173FE21AAD6 wds:Q43156241-55FA7A2E-E29D-4656-9966-CF7FCE93FBEF wds:Q43156241-C3A3945B-A85D-4C24-AFEE-5E547B89E017 wds:Q43156241-C963D273-BCB7-4B16-A7FC-5BD37E955754
wdt:P2093
Henning R Andersen Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events Investigators Ad J van Boven Luc Janssens Jiandong Lu Wladyslaw Pluta Bruce R Brodie
rdfs:label
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events). Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial
skos:prefLabel
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events).
schema:name
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events).
p:P50
wds:Q43156241-4F10FACB-FADD-41BC-A990-522D5325A2E0 wds:Q43156241-B5BC3D21-DD1A-4CED-AEE8-34E2D9A51C2D wds:Q43156241-B829C5B3-7A34-4AC4-8AED-7E38ED0AFA49 wds:Q43156241-C572A771-5B3B-439D-9941-A71473F9E8A4 wds:Q43156241-DD647977-8581-4CC3-976D-A4CCE151C63A wds:Q43156241-E5BF17C0-1587-4379-A775-3BB6A48D3044 wds:Q43156241-F061544A-E2BA-41BD-BDB1-732BCAB1036C wds:Q43156241-1330570A-79CA-463F-B497-4D4001FBCB18 wds:Q43156241-57985E9F-5CE2-4F77-8D43-84423E01EF5F wds:Q43156241-6D4F71DF-B65D-4CD2-BFF0-82FEE3C0459D wds:Q43156241-84E374B9-3F43-4152-968D-F129F3FDF666 wds:Q43156241-9A1D54D7-F0D1-43E3-A23F-C55D610D9536 wds:Q43156241-AA486943-A0BE-497A-BDF1-A167DDB06DCA wds:Q43156241-B2C65CCE-29E9-4F93-A7B1-5062EC8CE837
wdt:P50
wd:Q12045089 wd:Q114292276 wd:Q114292275 wd:Q95603865 wd:Q5387640 wd:Q28468989 wd:Q1308604 wd:Q63645100 wd:Q87852347 wd:Q62070116 wd:Q39026591 wd:Q48860774 wd:Q88627483 wd:Q62496584
p:P1476
wds:Q43156241-0BF33A74-3650-48B7-89E8-C9B16F4F45FD
wdt:P1476
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events).
p:P304
wds:Q43156241-249BAC86-8C95-46A7-9783-491DC5DED3E0
wdt:P304
203-212
p:P31
wds:Q43156241-20327C88-61AC-439E-8CA7-E641FA480C57
wdt:P31
wd:Q13442814
p:P698
wds:Q43156241-2AF08528-97FA-4A18-89CF-5A879E4C57B2
wdtn:P698
n12:20170878
wdt:P698
20170878
p:P1433
wds:Q43156241-182EEB25-4FB0-4211-9223-495110E12645
wdt:P1433
wd:Q15816248
p:P433
wds:Q43156241-489DDCC4-03DD-472B-B408-41D6560AF7C6
p:P478
wds:Q43156241-5A0B1F86-2492-492F-A325-0972D8F2B0FB
wdt:P433
2
wdt:P478
3
p:P356
wds:Q43156241-416147A8-4696-471F-A917-AD854F80776A
wdtn:P356
n9:J.JCIN.2009.11.012
wdt:P356
10.1016/J.JCIN.2009.11.012
p:P5875
wds:Q43156241-FAFB0832-DE27-4F1E-B57A-7AEB70525F79
wdt:P5875
41507663